Literature DB >> 19426288

Mortality among opiate users: opioid maintenance therapy, age and causes of death.

Thomas Clausen1, Helge Waal, Magne Thoresen, Michael Gossop.   

Abstract

AIMS: This study investigates how age of opioid users is related to causes of death prior to, during and after opioid maintenance treatment (OMT), and estimates risks of death from various causes in relation to age. DESIGN, SETTING AND PARTICIPANTS: Data on all opiate dependents in Norway (1997-2003) who applied for and were accepted for OMT (n = 3789) were cross-linked with the Norwegian death register. The total observation time was 10 934 person-years.
FINDINGS: A total of 213 deaths was recorded. Of these, 73% were subject to autopsy, and causes of death were known for 208 cases: the overall death rate was 1.9%. Deaths were due to drug overdose (54%), somatic (32%) and traumatic causes (14%). Overdose deaths among all age groups were reduced during OMT but age had a differential effect upon risk when out of treatment. Younger opioid users were at greater risk of overdose before entering treatment; older users were at greater risk after leaving treatment. Older OMT patients were at higher risk of both somatic and traumatic deaths, and deaths during OMT were most likely to be due to somatic causes.
CONCLUSIONS: The high rates of overdose prior to and after treatment emphasize the need to provide rapid access to OMT, to retain patients in treatment and to re-enrol patients. The high prevalence among older patients of deaths due to somatic causes has implications for screening, treatment and referral, and may also lead to increased treatment costs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19426288     DOI: 10.1111/j.1360-0443.2009.02570.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  43 in total

1.  Interim treatment: Bridging delays to opioid treatment access.

Authors:  Stacey C Sigmon
Journal:  Prev Med       Date:  2015-04-30       Impact factor: 4.018

2.  A stage I pilot study of acceptance and commitment therapy for methadone detoxification.

Authors:  Angela L Stotts; Charles Green; Akihiko Masuda; John Grabowski; Kelly Wilson; Thomas F Northrup; F Gerard Moeller; Joy M Schmitz
Journal:  Drug Alcohol Depend       Date:  2012-03-15       Impact factor: 4.492

3.  Negotiating place and gendered violence in Canada's largest open drug scene.

Authors:  Ryan McNeil; Kate Shannon; Laura Shaver; Thomas Kerr; Will Small
Journal:  Int J Drug Policy       Date:  2013-11-22

Review 4.  The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review.

Authors:  Kelly E Dunn; Stacey C Sigmon; Eric C Strain; Sarah H Heil; Stephen T Higgins
Journal:  Drug Alcohol Depend       Date:  2011-07-08       Impact factor: 4.492

5.  Interim methadone treatment compared to standard methadone treatment: 4-month findings.

Authors:  Robert P Schwartz; Sharon M Kelly; Kevin E O'Grady; Devang Gandhi; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2011-02-24

6.  Potential Years of Life Lost Due to Premature Mortality Among Treatment-Seeking Illicit Drug Users in Finland.

Authors:  Ifeoma N Onyeka; Caryl M Beynon; Ilkka Vohlonen; Jari Tiihonen; Jaana Föhr; Kimmo Ronkainen; Jussi Kauhanen
Journal:  J Community Health       Date:  2015-12

7.  The relationship between US heroin market dynamics and heroin-related overdose, 1992-2008.

Authors:  George Unick; Daniel Rosenblum; Sarah Mars; Daniel Ciccarone
Journal:  Addiction       Date:  2014-08-04       Impact factor: 6.526

8.  Staff attitudes and the associations with treatment organisation, clinical practices and outcomes in opioid maintenance treatment.

Authors:  Linn Gjersing; Helge Waal; John R M Caplehorn; Michael Gossop; Thomas Clausen
Journal:  BMC Health Serv Res       Date:  2010-07-06       Impact factor: 2.655

9.  Bridging waitlist delays with interim buprenorphine treatment: initial feasibility.

Authors:  Stacey C Sigmon; Andrew C Meyer; Bryce Hruska; Taylor Ochalek; Gail Rose; Gary J Badger; John R Brooklyn; Sarah H Heil; Stephen T Higgins; Brent A Moore; Robert P Schwartz
Journal:  Addict Behav       Date:  2015-07-29       Impact factor: 3.913

10.  Leaving buprenorphine treatment: patients' reasons for cessation of care.

Authors:  Jan Gryczynski; Shannon Gwin Mitchell; Jerome H Jaffe; Kevin E O'Grady; Yngvild K Olsen; Robert P Schwartz
Journal:  J Subst Abuse Treat       Date:  2013-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.